BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer

被引:42
|
作者
Tammaro, Claudia [1 ]
Raponi, Michela [1 ]
Wilson, David I. [1 ]
Baralle, Diana [1 ]
机构
[1] Univ Southampton, Southampton Gen Hosp, Inst Dev Sci Bldg, Human Dev & Hlth Acad Unit,Fac Med, Southampton SO16 6YD, Hants, England
关键词
alternative splicing; breast cancer early-onset 1 (BRCA1); cancer; BREAST-CANCER; MICE LACKING; CELLS; OVEREXPRESSION; MUTATIONS; GENE; BRCA1-DELTA-11; HYPERPLASIA; VARIANTS; PROTEINS;
D O I
10.1042/BST20120140
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 (breast cancer early-onset 1) alternative splicing levels are regulated in a cell-cycle- and cell-type-specific manner, with splice variants being present in different proportions in tumour cell lines as well as in normal mammary epithelial cells. The importance of this difference in the pathogenesis of breast cancer has yet to be determined. Developing an understanding of the impact of BRCA1 isoform ratio changes on cell phenotype will be of value in breast cancer and may offer therapeutic options. In the present paper, we describe the splicing isoforms of BRCA1 exon 11, their possible role in cancer biology and the importance of maintaining a balanced ratio.
引用
收藏
页码:768 / 772
页数:5
相关论文
共 50 条
  • [41] A missense variant within BRCA1 exon 23 causing exon skipping
    Rouleau, Etienne
    Lefol, Cedrick
    Moncoutier, Virginie
    Castera, Laurent
    Houdayer, Claude
    Caputo, Sandrine
    Bieche, Ivan
    Buisson, Monique
    Mazoyer, Sylvie
    Stoppa-Lyonnet, Dominique
    Nogues, Catherine
    Lidereau, Rosette
    [J]. CANCER GENETICS AND CYTOGENETICS, 2010, 202 (02) : 144 - 146
  • [42] A change in the last base of BRCA1 exon 23, 5586G→A, results in abnormal RNA splicing
    Ladopoulou, A
    Konstantopoulou, I
    Armaou, S
    Efstathiou, E
    Mihalatos, M
    Nasioulas, G
    Bardi, G
    Pandis, N
    Yannoukakos, D
    [J]. CANCER GENETICS AND CYTOGENETICS, 2002, 134 (02) : 175 - 177
  • [43] Detection of BRCA1 whole exon duplications in breast/ovarian cancer families by MAPH
    Rad, IA
    Sharif, AL
    Raeburn, JA
    Blamey, RW
    Chan, SY
    Armour, JAL
    Cross, GS
    [J]. JOURNAL OF MEDICAL GENETICS, 2000, 37 : S36 - S36
  • [44] Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test
    DeBenedetti, VMG
    Radice, P
    Mondini, P
    Spatti, G
    Conti, A
    Illeni, MT
    Caligo, MA
    Cipollini, G
    Bevilaqua, G
    Pilotti, S
    Pierotti, MA
    [J]. ONCOGENE, 1996, 13 (06) : 1353 - 1357
  • [45] Screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients
    El Khachibi, Meryam
    Diakite, Brehima
    Hamzi, Khalil
    Badou, Abdallah
    Senhaji, Mohamed Amine
    Bakhchane, Amina
    Jouhadi, Hassan
    Barakat, Abdelhamid
    Benider, Abdellatif
    Nadifi, Sellama
    [J]. BMC CANCER, 2015, 15
  • [46] Screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients
    Meryam El Khachibi
    Brehima Diakite
    Khalil Hamzi
    Abdallah Badou
    Mohamed Amine Senhaji
    Amina Bakhchane
    Hassan Jouhadi
    Abdelhamid Barakat
    Abdellatif Benider
    Sellama Nadifi
    [J]. BMC Cancer, 15
  • [47] Mutation screening of BRCA1 axon 11 in Bulgarian breast cancer
    Mitkova, A.
    Dodova, R.
    Vlahova, A.
    Dikov, T.
    Sedloev, T.
    Jonkov, A.
    Kremensky, I.
    Christova, S.
    Kaneva, R.
    [J]. EJC SUPPLEMENTS, 2008, 6 (09): : 102 - 102
  • [48] BRCA1 and prostate cancer
    Rosen, EM
    Fan, SJ
    Goldberg, ID
    [J]. CANCER INVESTIGATION, 2001, 19 (04) : 396 - 412
  • [49] Intricacies of BRCA1 genome integrity control and cancer suppression functions
    Livingston, D.
    [J]. EJC SUPPLEMENTS, 2010, 8 (05): : 87 - 87
  • [50] Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice
    Richard Bachelier
    Xiaoling Xu
    Xaoyan Wang
    Wenmei Li
    Mayumi Naramura
    Hua Gu
    Chu-Xia Deng
    [J]. Oncogene, 2003, 22 : 528 - 537